Barrett's esophagus: proton pump inhibitors and chemoprevention II Academic Article

abstract

• The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

authors

• Richter, Joel E
• Penagini, Roberto
• Pohl, Daniel
• Dvorak, Katerina
• Goldman, Aaron
• Savarino, Edoardo
• Zentilin, Patrizia
• Savarino, Vincenzo
• Watson, Joshua T
• Wong, Roy KH
• Pace, Fabio
• Casini, Valentina
• Peura, David A
• Herzig, Shoshana Joy
• Kamiya, Takeshi
• Pelosini, Iva
• Scarpignato, Carmelo
• Armstrong, David
• DeVault, Kenneth R
• Bechi, Paolo
• Taddei, Antonio
• Freschi, Giancarlo
• Ringressi, Maria Novella
• Degli'Innocenti, Duccio Rossi
• Castiglione, Francesca
• Masini, Emmanuella
• Hunt, Richard H

status

• published 

publication date

• September 2011

has subject area

• Barrett Esophagus (MeSH)
• Chemoprevention (MeSH)
• General Science & Technology (Science Metrix)
• Humans (MeSH)
• Monitoring, Physiologic (MeSH)
• Proton Pump Inhibitors (MeSH)
• Treatment Outcome (MeSH)

published in

• Annals of the New York Academy of Sciences  Journal

keywords

• Barrett Esophagus
• Chemoprevention
• Humans
• Monitoring, Physiologic
• Proton Pump Inhibitors
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1111/j.1749-6632.2011.06048.x

PubMed ID

• 21950810

start page

• 114

end page

• 139

volume

• 1232

issue

• 1